[1]
M. Ersoy, “Comparative analysis of cisplatin tolerability in head and neck, bladder, and cervical cancers: Does the primary tumor site influence toxicity profiles?”, J Bionic Mem, vol. 5, no. 2, pp. 24–31, Aug. 2025.